OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase
Mikołaj Żmudziński, Wioletta Rut, Kamila Olech, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Selenization of Small Molecule Drugs: A New Player on the Board
Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7759-7787
Closed Access | Times Cited: 21

Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1

New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
Sourav Samanta, Firoz Akhter, Anuradha Roy, et al.
Brain (2023) Vol. 147, Iss. 5, pp. 1710-1725
Open Access | Times Cited: 21

New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 8

Selenium compounds as promising antiviral agents
Vimal K. Jain, K. Indira Priyadarsini
New Journal of Chemistry (2024) Vol. 48, Iss. 15, pp. 6534-6552
Closed Access | Times Cited: 7

Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides
Hugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 10, pp. 3469-3476
Open Access | Times Cited: 4

Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways
Xin Zhang, Keesiang Lim, Yujia Qiu, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 151-151
Open Access

Recent Insights into Bioactive Dichalcogen Derivatives: From Small Molecules to Complex Materials
Leire Gaviria-Soteras, Arun Sharma, Carmen Sanmartín, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2436-2436
Open Access

Phototherapy of granuloma annulare: a single center retrospective study
Ines Katharina Himmelstoss, Franz J. Legat, Alexandra Gruber‐Wackernagel, et al.
Photochemical & Photobiological Sciences (2025)
Open Access

Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection
Amanda Resende Tucci, Raquel Mello da Rosa, Alice Santos Rosa, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6696-6696
Open Access | Times Cited: 10

Viral deubiquitinating proteases and the promising strategies of their inhibition
Vera Jannie Elisabeth van Vliet, Anuradha De Silva, Brian L. Mark, et al.
Virus Research (2024) Vol. 344, pp. 199368-199368
Open Access | Times Cited: 3

3C-like proteases in SARS-CoV-2
Kenana Al Adem, Juliana C. Ferreira, Adrian J. Villanueva, et al.
Bioscience Reports (2024)
Open Access | Times Cited: 3

Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2
Jobin Thomas, Anupam Ghosh, Shivendu Ranjan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19
Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, et al.
BioChem (2024) Vol. 4, Iss. 3, pp. 268-299
Open Access | Times Cited: 2

New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides
Luca Sancineto, Francesca Mangiavacchi, Agnieszka Dąbrowska, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2229-2229
Open Access | Times Cited: 6

Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition
Xin Li, Yongcheng Song
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18642-18655
Closed Access | Times Cited: 1

New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides
Luca Sancineto, Francesca Mangiavacchi, Agnieszka Dąbrowska, et al.
(2024)
Open Access | Times Cited: 1

Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
Mobin Ghazaiean, Aily Aliasgharian, Hossein Karami, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3

New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides
Luca Sancineto, Francesca Mangiavacchi, Agnieszka Dąbrowska, et al.
Research Square (Research Square) (2024)
Open Access

Page 1 - Next Page

Scroll to top